Cart
sales@molnova.com
20(21)-Dehydrolucidenic acid A
CAS No. 852936-69-7
20(21)-Dehydrolucidenic acid A( —— )
Catalog No. M31456 CAS No. 852936-69-7
20(21)-dehydrolucidenic acid A is a natural product from Ganoderma lucidum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 576 | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name20(21)-Dehydrolucidenic acid A
-
NoteResearch use only, not for human use.
-
Brief Description20(21)-dehydrolucidenic acid A is a natural product from Ganoderma lucidum.
-
Description20(21)-dehydrolucidenic acid A is a natural product from Ganoderma lucidum.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number852936-69-7
-
Formula Weight456.6
-
Molecular FormulaC27H36O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2,3-Dihydrobenzofura...
2,3-Dihydro-5-benzofuranacetic Acid is used as Pharmaceutical material and intermeidates.
-
Amine-PEG3-Biotin
Amine-PEG3-Biotin can be used as a signal amplification label.
-
SARS-CoV-2 Mpro-IN-9
SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.
